loading
Overview News Price History Option Chain Financials Why RLAY Down? Discussions Forecast

Why is Relay Therapeutics Inc (RLAY) Stock down?

We've noticed a 6.67% decline in Relay Therapeutics Inc (RLAY) stock during the 2024-12-18 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
18 Apr, 2023:

RLAY stock may have declined due to the release of positive initial clinical data for RLY-2608, an investigational inhibitor of PI3Kα, presented at the AACR Annual Meeting 2023. The drug demonstrated selective target engagement and a favorable safety profile.

https://finance.yahoo.com/news/relay-therapeutics-announces-initial-clinical-144000159.html

Similar to RLAY

biotechnology SMMT
$17.87
price down icon 2.88%
biotechnology INCY
$68.84
price up icon 2.65%
biotechnology MRNA
$39.39
price down icon 0.43%
biotechnology UTHR
$359.58
price down icon 0.16%
biotechnology BGNE
$176.50
price up icon 1.02%
biotechnology BNTX
$113.08
price up icon 1.56%
Open in Yahoo | Open in Google | Open in Finviz | Open in MarketWatch | Open in EDGAR | Open in Reuters
Cap:     |  Volume (24h):